Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,407 | 80 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $212.63 | 12 | $0 (2024) |
| ABBVIE INC. | $195.73 | 10 | $0 (2024) |
| GlaxoSmithKline, LLC. | $141.55 | 8 | $0 (2024) |
| Novo Nordisk Inc | $98.16 | 5 | $0 (2024) |
| Lilly USA, LLC | $72.77 | 4 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $72.16 | 5 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $67.18 | 5 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $66.41 | 4 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $66.26 | 4 | $0 (2023) |
| Exact Sciences Corporation | $65.95 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $268.40 | 15 | ABBVIE INC. ($42.71) |
| 2023 | $800.15 | 45 | PFIZER INC. ($191.86) |
| 2022 | $322.27 | 19 | Novo Nordisk Inc ($60.61) |
| 2021 | $15.90 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($15.90) |
All Payment Transactions
80 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Durable Pump | ||||||
| 10/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Atland Pharmaceuticals, LLC | ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE (Drug), TOLMETIN SODIUM | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Pain | ||||||
| 09/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Oncology | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Gastroenterology | ||||||
| 09/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Respiratory | ||||||
| 08/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Oncology | ||||||
| 06/26/2024 | Medline Industries LP | — | Food and Beverage | In-kind items and services | $14.62 | General |
| 06/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: RESPIRATORY | ||||||
| 05/15/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Endocrinology | ||||||
| 10/25/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Endocrinology | ||||||
| 09/06/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Biological | ||||||
| 08/29/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: RESPIRATORY | ||||||
| 08/25/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/11/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/09/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: RESPIRATORY | ||||||
| 08/02/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2023 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/27/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.77 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 753 | 1,084 | $124,864 | $60,432 |
| 2022 | 10 | 320 | 370 | $36,802 | $19,384 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 181 | $29,901 | $13,391 | 44.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 50 | 120 | $18,550 | $10,712 | 57.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 87 | 93 | $14,410 | $7,948 | 55.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 43 | 92 | $11,005 | $5,458 | 49.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 39 | 40 | $11,154 | $5,204 | 46.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 35 | 35 | $6,493 | $4,173 | 64.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 68 | $8,265 | $3,404 | 41.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 13 | 15 | $3,180 | $2,246 | 70.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 20 | $3,720 | $1,949 | 52.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 110 | 158 | $1,580 | $1,310 | 82.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 28 | 28 | $6,720 | $1,045 | 15.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 12 | 12 | $1,344 | $878.82 | 65.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,797 | $820.10 | 29.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 27 | 27 | $810.00 | $451.44 | 55.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $1,980 | $441.13 | 22.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 11 | $935.00 | $420.09 | 44.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 25 | 41 | $1,460 | $381.84 | 26.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 15 | 17 | $340.00 | $161.84 | 47.6% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 11 | 44 | $76.00 | $16.26 | 21.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 11 | 14 | $84.00 | $14.55 | 17.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 12 | 46 | $59.00 | $4.09 | 6.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 80 | $11,600 | $7,378 | 63.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 78 | 86 | $8,925 | $5,620 | 63.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $4,775 | $1,736 | 36.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 12 | 12 | $2,436 | $1,473 | 60.5% |
About Tyler Rushforth
Tyler Rushforth is a Family Medicine healthcare provider based in Cullman, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2017. The National Provider Identifier (NPI) number assigned to this provider is 1114436219.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tyler Rushforth has received a total of $1,407 in payments from pharmaceutical and medical device companies, with $268.40 received in 2024. These payments were reported across 80 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,407).
As a Medicare-enrolled provider, Rushforth has provided services to 1,073 Medicare beneficiaries, totaling 1,454 services with total Medicare billing of $79,816. Data is available for 2 years (2022–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Cullman, AL
- Active Since 09/21/2017
- Last Updated 11/01/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1114436219
Products in Payments
- ELIQUIS (Drug) $256.12
- VRAYLAR (Drug) $177.90
- TRELEGY ELLIPTA (Drug) $127.88
- Rybelsus (Drug) $74.94
- XARELTO (Drug) $72.16
- Cologuard Collection Kit (Device) $65.95
- BREZTRI (Drug) $54.28
- Dexcom G6 Transmitter (Medical Supply) $53.42
- XIFAXAN (Drug) $52.53
- EMGALITY (Drug) $52.30
- TRADJENTA (Drug) $46.52
- KRYSTEXXA (Biological) $39.84
- Myrbetriq (Drug) $29.08
- MINIMED 780G (Device) $24.20
- Ozempic (Drug) $23.22
- PAXLOVID (Drug) $22.92
- YUPELRI (Drug) $21.38
- ENTRESTO (Drug) $20.83
- MOUNJARO (Drug) $20.47
- Veozah (Drug) $20.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cullman
Randall Quinn, Md, MD
Family Medicine — Payments: $9,340
Ben Bostick, M.d, M.D
Family Medicine — Payments: $9,230
Christopher Coccia, D.o, D.O
Family Medicine — Payments: $8,162
Alan Hanley, Md, MD
Family Medicine — Payments: $7,972
Thomas Montgomery, M.d, M.D
Family Medicine — Payments: $5,088
Dr. Carlos Villar-Gosalvez, M.d, M.D
Family Medicine — Payments: $4,828